Even though the fusion gene had been identified in breast cancer patients, the copy number amplicon (the one harboring the independent ERBB2 and GRB7 genes) had previously been reported in other cancer types, including gastric cancer [13,14]. This evidence concerns the gene ERBB2 and breast carcinoma.